These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 5352827)

  • 21. [Gonadal dysgenesis].
    Jancu J; Pertzelan A; Laron Z
    Harefuah; 1974 Jan; 86(2):77-80. PubMed ID: 4826061
    [No Abstract]   [Full Text] [Related]  

  • 22. Adult height in girls with Turner syndrome treated with low-dose estrogens and androgens.
    Lin TH; Kirkland RT; Kirkland JL
    Ann Pharmacother; 1994 May; 28(5):570-1. PubMed ID: 8068990
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Body height and dental development in patients with Turner's syndrome.
    Lindsten J; Filipsson R; Hall K; Leikrans S; Gustavson KH; Ryman N
    Helv Paediatr Acta; 1974; Suppl 34():33-46. PubMed ID: 4452638
    [No Abstract]   [Full Text] [Related]  

  • 24. [Anabolic steroids and growth].
    Bierich JR
    Minerva Med; 1971 Jun; 62(51):2572-9. PubMed ID: 5566870
    [No Abstract]   [Full Text] [Related]  

  • 25. Adult height and pubertal growth in Turner syndrome after treatment with recombinant growth hormone.
    Soriano-Guillen L; Coste J; Ecosse E; Léger J; Tauber M; Cabrol S; Nicolino M; Brauner R; Chaussain JL; Carel JC
    J Clin Endocrinol Metab; 2005 Sep; 90(9):5197-204. PubMed ID: 15998771
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Moving toward an understanding of hormone replacement therapy in adolescent girls: looking through the lens of Turner syndrome.
    Davenport ML
    Ann N Y Acad Sci; 2008; 1135():126-37. PubMed ID: 18574218
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Turner syndrome: a virtually certain indication for growth hormone treatment].
    Rongen-Westerlaken C; Wit JM
    Tijdschr Kindergeneeskd; 1992 Oct; 60(5):155-63. PubMed ID: 1448805
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Long-term treatment of gonadal dysgenesis].
    Schmid-Tannwald I; Hauser GA
    Gynakol Rundsch; 1973; 13():Suppl 1:69-76. PubMed ID: 4798938
    [No Abstract]   [Full Text] [Related]  

  • 29. Influence of hormonal therapy on growth rate and bone age progression in patients with Turner syndrome.
    Gawlik A; Gawlik T; Koehler B; Malecka-Tendera E; Augustyn M; Woska W
    Endokrynol Pol; 2005; 56(2):136-44. PubMed ID: 16335681
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oxandrolone for growth promotion in Turner syndrome.
    Rosenbloom AL; Frias JL
    Am J Dis Child; 1973 Mar; 125(3):385-7. PubMed ID: 4692593
    [No Abstract]   [Full Text] [Related]  

  • 31. Turner's syndrome with concomitant hypopituitarism: case report.
    Efstathiadou Z; Tsatsoulis A
    Hum Reprod; 2000 Nov; 15(11):2388-9. PubMed ID: 11056139
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Yearly stepwise increments of the growth hormone dose results in a better growth response after four years in girls with Turner syndrome. Dutch Working Group on Growth Hormone.
    van Teunenbroek A; de Muinck Keizer-Schrama SM; Stijnen T; Jansen M; Otten BJ; Delemarre-van de Waal HA; Vulsma T; Wit JM; Rouwé CW; Reeser HM; Gosen JJ; Rongen-Westerlaken C; Drop SL
    J Clin Endocrinol Metab; 1996 Nov; 81(11):4013-21. PubMed ID: 8923853
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Clinical and biochemical studies in a female patient with mixed gonadal dysgenesis].
    Zimprich H
    Wien Klin Wochenschr; 1969 Jun; 81(25):475-8 passim. PubMed ID: 4241299
    [No Abstract]   [Full Text] [Related]  

  • 34. Enhanced linear growth responses in hypopituitary dwarfs treated with growth hormone plus androgen versus growth hormone alone.
    MacGillivray MH; Kolotkin M; Munschauer RW
    Pediatr Res; 1974 Feb; 8(2):103-8. PubMed ID: 4810507
    [No Abstract]   [Full Text] [Related]  

  • 35. Left middle finger metacarpophalangeal growth in Turner syndrome. Normal values and changes after growth hormone treatment.
    Chávez Meyer H; Ranke MB
    Horm Res; 1991; 35(3-4):109-12. PubMed ID: 1806463
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Growth hormone therapy of Turner syndrome: the impact of age of estrogen replacement on final height. Genentech, Inc., Collaborative Study Group.
    Chernausek SD; Attie KM; Cara JF; Rosenfeld RG; Frane J
    J Clin Endocrinol Metab; 2000 Jul; 85(7):2439-45. PubMed ID: 10902791
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of short stature in Turner syndrome.
    Stahnke N; Willig RP
    J Pediatr; 1980 Jan; 96(1):176-7. PubMed ID: 7350309
    [No Abstract]   [Full Text] [Related]  

  • 38. Hormones and genes of importance in bone physiology and their influence on bone mineralization and growth in Turner syndrome.
    Andrade AC; Baron J; Manolagas SC; Shaw NJ; Rappold GA; Donaldson MD; Gault EJ; Sävendahl L
    Horm Res Paediatr; 2010; 73(3):161-5. PubMed ID: 20197667
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of oxandrolone in Turner syndrome.
    Root AW
    J Pediatr; 1980 Jan; 96(1):168-9. PubMed ID: 7350303
    [No Abstract]   [Full Text] [Related]  

  • 40. [Analysis of the results of the long-term estrogen therapy of gonadal dysgenesis].
    Savitskiĭ GA
    Akush Ginekol (Mosk); 1978 Oct; (10):41-4. PubMed ID: 362968
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.